Jinli Ding1, Yunyun Duan1, Zhizheng Zhuo1, Yawei Yuan2, Guiqing Zhang2, Qingwei Song3, Bingbing Gao3, Bing Zhang4, Maoxue Wang4, Linlin Yang5, Yang Hou5, Fenglian Zheng1, Xiaoya Chen6, Yishi Wang7, and Yaou Liu1
1Department of Radiology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China, 2Beijing Royal Integrative Medicine Hospital, Beijing, China, 3First Affiliated Hospital of Dalian Medical University, Dalian, China, 4Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School, Jiangsu, China, 5Shengjing Hospital of China Medical University, Shenyang, China, 6the First Affiliated Hospital of Chongqing Medical University, Chongqing, China, 7Philips Healthcare, Beijing, China
Synopsis
Clinical feasibility of using Compressed SENSE (CS-SENSE) technology to shorten
the scan time of Time-of-flight (TOF) magnetic resonance angiography (MRA) and optimal
acceleration factor were investigated via a multi-center study. Ninety subjects
underwent 8 customized TOF-MRA sequences including sequences with CS-SENSE technology,
SENSE technology and without acceleration technology. Subjective assessments
including evaluations of artery branches and artifacts, and objective measurements
including signal-to-noise ratio, contrast-to-noise ratio and peak signal-to-noise
ratio were performed. The results indicated that TOF-MRA using CS-SENSE with an
optimal acceleration factor (4 to 6) provided comparable results compared with traditional
TOF-MRA sequences, and significantly increased the scan efficiency.
Introduction
Time-of-flight (TOF) magnetic resonance angiography (MRA) is one of the most
commonly used MR sequences in the cerebrovascular examinations. Although
contrast agent injection is not needed for TOF-MRA, it takes a relatively long
scan time which needs patient cooperation1. Application of Compressed
SENSE (CS-SENSE) technology can shorten the scan time of MRA and increase the
efficiency. However, the clinical feasibility and the optimal acceleration factor
of CS-SENSE technology in MRA have not been investigated.Objective
This study aimed to evaluate the clinical application and effectiveness of
accelerated TOF-MRA by employing CS-SENSE technology.Methods
Ninety subjects including 42 healthy volunteers and 48 patients with cerebrovascular diseases were enrolled in this study with informed consents (49
males and 41 females with age ranged from 12 to 71), and all the data were prospectively
acquired from a multi-center study with 5 sites (including Beijing Tiantan Hospital,
Capital Medical University, 26 cases; Beijing Royal Integrative
Medicine Hospital, 24 cases; Shengjing hospital of China Medical University, 15
cases; Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical
School, 15 cases; and First Affiliated Hospital of Dalian Medical University, 10
cases) on 3.0T MR systems (Ingenia CX, Philips Healthcare, the
Netherlands). All patients underwent 8 different customized TOF-MRA sequences which
included 5 sequences utilizing CS-SENSE technology with different acceleration factors
(2, 4, 6, 8 and 10, denoted as CS2, CS4, CS6, CS8 and CS10 respectively), 2 sequences
utilizing traditional SENSE technology with different SENSE factors (2 and 4, denoted
as SF2 and SF4 respectively), and 1 sequence without acceleration technology used
as reference. Signal to noise ratio (SNR), contrast to noise ratio
(CNR) and peak signal to noise ratio (PSNR) were calculated by setting
distal M1 segment of the middle cerebral artery as the region of interest (ROI)
and setting the splenium of the corpus callosum which revealed a relatively uniform
intensity distribution as a contrast2,3. The image quality which focused
on the visualization of artery branches (including A2 and A3 of the anterior cerebral
artery, M2 and M3 segments of the middle cerebral artery, and P2 and P3 segments
of the posterior cerebral artery) and overall image impression was independently
evaluated by two experienced radiologists using a
five-grade scoring system (1~unsatisfactory, 2~fair,
3~average, 4~good, and 5~excellent.). The artifacts were
evaluated using a four-grade scoring system (1~severe artifact, 2~moderate artifact, 3~mild artifact, and 4~no artifact.).
Finally, one optimal sequence for each patient was determined by each radiologist
after comprehensively considering the scan time and image quality. Statistical analysis
was carried out using SPSS 19.0.Results
Compared with the reference sequence, the scan times of TOF-MRA were
reduced by 47.9%, 73.2%, 82.0%, 86.3% and 89.0% by setting the CS-SENSE acceleration
factor as 2, 4, 6, 8 and 10 respectively (Figure 1). The SNR, PSNR and CNR of the
8 sequences are listed in Table 1. The scorings of artery branches, overall image
impression and artifacts of the eight sequences are shown in Table 2. For the scoring
system, there was a good consistency between the results from different radiologists
(K=0.872, P<0.05). Image scorings of CS2 sequence and SF2 sequence were
nearly the same, however, image scoring of SF4 was obviously lower than that of
CS4 and CS6 sequence. CS4 sequence (72%) and CS6 sequence (28%) were determined
by two radiologists as the optimal choices after comprehensively considering the
scan time and image quality. Axial images at the middle cerebral artery level of
the 8 sequences for a patient with cerebrovascular disease are shown in Figure 2
and typical MIP images are shown in Figure 3. The distal tiny branches were unclear
or even missing when the CS-SENSE acceleration factor was set too high (such as
CS-SENSE acceleration factor was bigger than 6, as Figure 3 shows).Discussion and Conclusion
For TOF-MRA sequence, image quality is generally acceptable or even
better by employing optimal CS-SENSE acceleration factor compared to the traditional
SENSE technology. The subjective scorings and objective measurements degrade with
the increase of CS-SENSE acceleration factor. The optimal CS-SENSE acceleration factor
of 4 to 6 is recommended by balancing the shortened scan time and diagnostic image
quality and thus the image acquisition efficiency increases by about 274% to
454% compared to the reference. There are some limitations in the current study.
It only presents a preliminary analysis of CS-SENSE technology in the
application of TOF-MRA utilizing the data acquired from multi-center till now.
In the future study, more patients will be enrolled in this study, and more
comprehensive subjective assessments and objective measurements will be
performed in the cerebrovascular diseases, especially for hemadostenosis
and aneurysm.Acknowledgements
References
1. Gaa J, Weidauer S, Requardt
M, et al. Comparison of Intracranial 3D-ToF-MRA With and Without Parallel Acquisition
Techniques at 1.5T and 3.0T: Preliminary Results[J]. Acta Radiologica, 2004, 45(3):327-332.
2. Bratke G, Rau R, Weiss K, et al. Accelerated MRI of the Lumbar Spine
Using Compressed Sensing: Quality and Efficiency[J]. Journal of Magnetic Resonance
Imaging, 2019, 49(7):e164-e175.
3. Vranic J E, Cross N M, Wang Y, et al. Compressed Sensing–Sensitivity
Encoding (CS-SENSE) Accelerated Brain Imaging: Reduced Scan Time without
Reduced Image Quality[J]. American Journal of Neuroradiology, 2019, 40(1):92-98.